147 related articles for article (PubMed ID: 3384359)
41. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
Li S; Feng H; Zhu J; Zhong C; Leng X; Du R
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169
[TBL] [Abstract][Full Text] [Related]
42. Isosorbide dinitrate in experimental portal hypertension: a study of factors that modulate the hemodynamic response.
Blei AT; Gottstein J
Hepatology; 1986; 6(1):107-11. PubMed ID: 3943776
[TBL] [Abstract][Full Text] [Related]
43. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
[TBL] [Abstract][Full Text] [Related]
44. Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension.
Ribas J; Angrill J; Barberà JA; García-Pagán JC; Roca J; Bosch J; Rodriguez-Roisin R
Eur Respir J; 1999 Jan; 13(1):210-2. PubMed ID: 10836350
[TBL] [Abstract][Full Text] [Related]
45. Role of pentobarbitone anaesthesia and sympathetic tone in the haemodynamic effects of isosorbide dinitrate in rats with cirrhosis.
Kirstetter P; Pilette C; Moreau R; Cailmail S; Safka V; Soupison T; Lebrec D
J Gastroenterol Hepatol; 1996 Mar; 11(3):230-5. PubMed ID: 8742918
[TBL] [Abstract][Full Text] [Related]
46. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
[TBL] [Abstract][Full Text] [Related]
47. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
[TBL] [Abstract][Full Text] [Related]
48. [Effects of Radix angelicae sinensis on systemic and portal hemodynamics in cirrhotics with portal hypertension].
Huang Z; Guo B; Liang K
Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):15-8. PubMed ID: 9275639
[TBL] [Abstract][Full Text] [Related]
49. Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions.
Blei AT; Garcia-Tsao G; Groszmann RJ; Kahrilas P; Ganger D; Morse S; Fung HL
Gastroenterology; 1987 Sep; 93(3):576-83. PubMed ID: 3301517
[TBL] [Abstract][Full Text] [Related]
50. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
51. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
[TBL] [Abstract][Full Text] [Related]
52. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
[TBL] [Abstract][Full Text] [Related]
53. Effect of sublingual isosorbide dinitrate on wedged hepatic venous pressure in cirrhotics with portal hypertension.
Qureshi H; Zuberi SJ; Faruqui A
Indian J Gastroenterol; 1988 Jul; 7(3):161-2. PubMed ID: 3397139
[No Abstract] [Full Text] [Related]
54. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
[TBL] [Abstract][Full Text] [Related]
55. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P
J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
[TBL] [Abstract][Full Text] [Related]
56. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
[TBL] [Abstract][Full Text] [Related]
57. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
58. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
Bellis L; Berzigotti A; Abraldes JG; Moitinho E; García-Pagán JC; Bosch J; Rodés J
Hepatology; 2003 Feb; 37(2):378-84. PubMed ID: 12540788
[TBL] [Abstract][Full Text] [Related]
59. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
[TBL] [Abstract][Full Text] [Related]
60. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
Albillos A; García-Pagán JC; Iborra J; Bandi JC; Cacho G; Pérez-Paramo M; Escorsell A; Calleja JL; Escartín P; Bosch J
Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]